Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
NCT ID: NCT02181569
Last Updated: 2026-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
198 participants
OBSERVATIONAL
2014-07-10
2019-03-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep and Emotional Reactivity in Alcohol Use Disorder
NCT04979507
Reducing Alcohol Use in Depressed Patients
NCT00183079
Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD
NCT01663337
Pharmacotherapy and Mechanisms of Sleep Disturbance in Alcohol Dependence
NCT01014533
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome
NCT03818191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment seeking participants with alcohol dependence
Treatment seeking individuals with alcohol dependence who are admitted into a 28-day inpatient treatment program.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older,
* Enrolled on the screening, assessment and treatment protocol (14-AA-0181)
* Have been an inpatient for 21 days or more preceding discharge,
* Not enrolled onto a pharmacologic intervention study,
* Able to understand the study, and
* Willing to return to the Clinical Center 4-6 weeks after being discharged from inpatient treatment for a follow-up visit.
Exclusion Criteria
* Less than 18 years of age,
* Unable to understand the purpose of the study,
* Unable to provide informed consent,
* Unable to follow the study design, or
* Unable or unwilling to return to the Clinical Center 4-6 weeks after being discharged from inpatient treatment for a follow-up visit.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
National Institutes of Health Clinical Center (CC)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer J Barb-Smith, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
National Institutes of Health Clinical Center (CC)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-CC-0143
Identifier Type: -
Identifier Source: secondary_id
140143
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.